Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Two ways to think about time in biotech :

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Jan 23, 2023 1:29pm

211 Views

Post# 35240204

RE:RE:Two ways to think about time in biotech :

UC Irvine cognitive scientist Donald Hoffman asserts that space-time has been proven not to be fundamental. Therefore humans are not smart enough to reach objective reality. That is to say nothing one perceives is real.

I agree with him, and have been trying to apply this to ONC/ONCY.

I shall look away and wait; perhaps meditate. If I continue to look I will be merely looking at an interface and not objective reality.

Hopefuly when I do look again, I shall be suprised not with objective reality, but a number greater than 5B.

Idle afternoon thoughts while we wait. Cheers

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity